Literature DB >> 21672499

Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume.

Paola Dazzan1, Carmine M Pariante2, Valeria Mondelli2, Annamaria Cattaneo2,3, Martino Belvederi Murri2, Marta Di Forti1, Rowena Handley1, Nilay Hepgul2, Ana Miorelli1, Serena Navari1, Andrew S Papadopoulos4, Katherine J Aitchison1,5, Craig Morgan1, Robin M Murray1.   

Abstract

BACKGROUND: Reduced brain-derived neurotrophic factor (BDNF) levels have been reported in the serum and plasma of patients with psychosis. The aim of this cross-sectional case-control study was to investigate potential causes and consequences of reduced BDNF expression in these patients by examining the association between BDNF levels and measures of stress, inflammation, and hippocampal volume in first-episode psychosis.
METHOD: Brain-derived neurotrophic factor, interleukin (IL)-6, and tumor necrosis factor (TNF)-α messenger RNA levels were measured in the leukocytes of 49 first-episode psychosis patients (DSM-IV criteria) and 30 healthy controls, all aged 18 to 65 years, recruited between January 2006 and December 2008. Patients were recruited from inpatient and outpatient units of the South London and Maudsley National Health Service Foundation Trust in London, United Kingdom, and the healthy controls were recruited from the same catchment area via advertisement and volunteer databases. In these same subjects, we measured salivary cortisol levels and collected information about psychosocial stressors (number of childhood traumas, number of recent stressors, and perceived stress). Finally, hippocampal volume was measured using brain magnetic resonance imaging in a subsample of 19 patients.
RESULTS: Patients had reduced BDNF (effect size, d = 1.3; P < .001) and increased IL-6 (effect size, d = 1.1; P < .001) and TNF-α (effect size, d = 1.7; P < .001) gene expression levels when compared with controls, as well as higher levels of psychosocial stressors. A linear regression analysis in patients showed that a history of childhood trauma and high levels of recent stressors predicted lower BDNF expression through an inflammation-mediated pathway (adjusted R(2) = 0.23, P = .009). In turn, lower BDNF expression, increased IL-6 expression, and increased cortisol levels all significantly and independently predicted a smaller left hippocampal volume (adjusted R(2) = 0.71, P < .001).
CONCLUSIONS: Biological changes activated by stress represent a significant factor influencing brain structure and function in first-episode psychosis through an effect on BDNF. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21672499      PMCID: PMC4082665          DOI: 10.4088/JCP.10m06745

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  71 in total

1.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change.

Authors:  Jens C Pruessner; Clemens Kirschbaum; Gunther Meinlschmid; Dirk H Hellhammer
Journal:  Psychoneuroendocrinology       Date:  2003-10       Impact factor: 4.905

Review 2.  The use of mifepristone in the treatment of neuropsychiatric disorders.

Authors:  Charles DeBattista; Joseph Belanoff
Journal:  Trends Endocrinol Metab       Date:  2006-03-10       Impact factor: 12.015

Review 3.  Physiology of the neurotrophins.

Authors:  G R Lewin; Y A Barde
Journal:  Annu Rev Neurosci       Date:  1996       Impact factor: 12.449

4.  Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses.

Authors:  N Durany; T Michel; R Zöchling; K W Boissl; F F Cruz-Sánchez; P Riederer; J Thome
Journal:  Schizophr Res       Date:  2001-10-01       Impact factor: 4.939

5.  Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics.

Authors:  Ana González-Pinto; Fernando Mosquera; Aitor Palomino; Susana Alberich; Arantza Gutiérrez; Karim Haidar; Patricia Vega; Sara Barbeito; Agurtzane Ortiz; Carlos Matute
Journal:  Int Clin Psychopharmacol       Date:  2010-07       Impact factor: 1.659

6.  Environmental enrichment, exercise and corticosterone affect endothelial cell proliferation in adult rat hippocampus and prefrontal cortex.

Authors:  Joakim Ekstrand; Johan Hellsten; Anders Tingström
Journal:  Neurosci Lett       Date:  2008-07-09       Impact factor: 3.046

7.  Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia.

Authors:  Ripu D Jindal; Anil K Pillai; Sahebrao P Mahadik; Kevin Eklund; Debra M Montrose; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2010-01-21       Impact factor: 4.939

8.  Low plasma brain-derived neurotrophic factor and childhood physical neglect are associated with verbal memory impairment in major depression--a preliminary report.

Authors:  Rodrigo Grassi-Oliveira; Lilian Milnitsky Stein; Rodrigo Pestana Lopes; Antonio L Teixeira; Moisés Evandro Bauer
Journal:  Biol Psychiatry       Date:  2008-04-11       Impact factor: 13.382

9.  Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions.

Authors:  Mila Roceri; Francesca Cirulli; Cassandra Pessina; Paolo Peretto; Giorgio Racagni; Marco A Riva
Journal:  Biol Psychiatry       Date:  2004-04-01       Impact factor: 13.382

10.  Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology.

Authors:  Marcia Kauer-Sant'Anna; Juliana Tramontina; Ana Cristina Andreazza; Keila Cereser; Sabrina da Costa; Aida Santin; Lakshmi N Yatham; Flavio Kapczinski
Journal:  Bipolar Disord       Date:  2007-06       Impact factor: 6.744

View more
  76 in total

Review 1.  Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?

Authors:  David Baumeister; Simone Ciufolini; Valeria Mondelli
Journal:  Psychopharmacology (Berl)       Date:  2015-08-14       Impact factor: 4.530

Review 2.  Inflammation and schizophrenia.

Authors:  Brian Kirkpatrick; Brian J Miller
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

Review 3.  Trauma and the psychosis spectrum: A review of symptom specificity and explanatory mechanisms.

Authors:  Lauren E Gibson; Lauren B Alloy; Lauren M Ellman
Journal:  Clin Psychol Rev       Date:  2016-08-31

4.  Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia.

Authors:  Harald Murck; Thomas Laughren; Femke Lamers; Rosalind Picard; Sebastian Walther; Donald Goff; Stephen Sainati
Journal:  Innov Clin Neurosci       Date:  2015 Mar-Apr

Review 5.  The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Authors:  Adriana P Hermida; William M McDonald; Kyle Steenland; Allan Levey
Journal:  Expert Rev Neurother       Date:  2012-11       Impact factor: 4.618

Review 6.  The cytokine model of schizophrenia: emerging therapeutic strategies.

Authors:  Ragy R Girgis; Samhita S Kumar; Alan S Brown
Journal:  Biol Psychiatry       Date:  2013-12-11       Impact factor: 13.382

7.  From stress to psychosis: whom, how, when and why?

Authors:  V Mondelli
Journal:  Epidemiol Psychiatr Sci       Date:  2014-06-06       Impact factor: 6.892

Review 8.  Altering the course of schizophrenia: progress and perspectives.

Authors:  Mark J Millan; Annie Andrieux; George Bartzokis; Kristin Cadenhead; Paola Dazzan; Paolo Fusar-Poli; Jürgen Gallinat; Jay Giedd; Dennis R Grayson; Markus Heinrichs; René Kahn; Marie-Odile Krebs; Marion Leboyer; David Lewis; Oscar Marin; Philippe Marin; Andreas Meyer-Lindenberg; Patrick McGorry; Philip McGuire; Michael J Owen; Paul Patterson; Akira Sawa; Michael Spedding; Peter Uhlhaas; Flora Vaccarino; Claes Wahlestedt; Daniel Weinberger
Journal:  Nat Rev Drug Discov       Date:  2016-03-04       Impact factor: 84.694

9.  Prefrontal Cortex Dysfunction Increases Susceptibility to Schizophrenia-Like Changes Induced by Adolescent Stress Exposure.

Authors:  Felipe V Gomes; Anthony A Grace
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

10.  Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.

Authors:  Yijuan Du; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.